Treatment of guanfacine toxicity with naloxone

Pediatric Emergency Care

Volumn 28, Issue 10, 2012, Pages 1060-1061

  Tsze, Daniel S ^a   Dayan, Peter S ^a  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

guanfacine; naloxone; toxicology

Indexed keywords

GUANFACINE; NALOXONE;

ARTICLE; ATTENTION DEFICIT DISORDER; BLOOD PRESSURE; BRADYCARDIA; CASE REPORT; CHILD; CONSCIOUSNESS; CONTINUOUS INFUSION; DRUG DOSE INCREASE; EMERGENCY CARE; EVENING DOSAGE; HEART RATE; HUMAN; HYPERTENSION; HYPOTENSION; LETHARGY; MALE; PRESCHOOL CHILD; SOMNOLENCE; SUSTAINED RELEASE FORMULATION;

ANTIHYPERTENSIVE AGENTS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BLOOD PRESSURE; CHILD, PRESCHOOL; ELECTROCARDIOGRAPHY; FOLLOW-UP STUDIES; GUANFACINE; HUMANS; HYPOTENSION; MALE; NALOXONE; NARCOTIC ANTAGONISTS;

EID: 84867373071     PISSN: 07495161     EISSN: 15351815     Source Type: Journal    
DOI: 10.1097/PEC.0b013e31826ce9f1     Document Type: Article

References (12)

1. Mehta H. Intuniv (guanfacine) BPCA Drug Use Review. Food Drug Adm. 2010. Reference ID: 2879839. Available at: Http://www.fda.gov/downloads/ AdvisoryCommittees/CommitteesMeetingMaterials/PediatricAdvisoryCommittee/ UCM255108.pdf. Accessed May 10, 2011.
2. Van Dyke MW, Bonace AL, Ellenhorn MJ. Guanfacine overdose in a pediatric patient. Vet Hum Toxicol. 1990;32:46-47.
3. Granier P, Arsac P, Debru JL. Guanfacine poisoning [in French]. Nouv Presse Med. 1982;11:1636-1637.
4. Minns AB, Clark RF, Schneir A. Guanfacine overdose resulting in initial hypertension and subsequent delayed, persistent orthostatic hypotension. Clin Toxicol (Phila). 2010;48:146-148.
5. Scahill L, Chappell PB, Kim YS, et al. A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. Am J Psychiatry. 2001;158: 1067-1074.
6. Hunt RD, Arnsten AF, Asbell MD. An open trial of guanfacine in the treatment of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 1995;34:50-54.
7. McGrath JC, Klein-Schwartz W. Epidemiology and toxicity of pediatric guanfacine exposures. Ann Pharmacother. 2002;36:1698-1703.
8. Cook P. Clonidine-induced unconsciousness: Reversal with naloxone. Anaesth Intensive Care. 1987;15:470-471.
9. Kulig K, Duffy J, Rumack BH, et al. Naloxone for treatment of clonidine overdose. JAMA. 1982;247:1697.
10. Tenenbein M. Naloxone in clonidine toxicity. Am J Dis Child. 1984;138:1084-1085.
11. Seger DL. Clonidine toxicity revisited. J Toxicol Clin Toxicol. 2002;40:145-155.
12. Arnsten AF, Scahill L, Findling RL. Alpha-2 adrenergic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: Emerging concepts from new data. J Child Adolesc Psychopharmacol. 2007;17:393-406.